Stockholders to Vote on Authorizing Issuance of 8M Shares for Hudson Bay Financing

summarizeSummary

Spectral AI is seeking shareholder approval to authorize the issuance of up to 8 million common shares to Hudson Bay Master Fund Ltd. from a previously closed financing agreement, which would result in significant dilution but was priced above the current market.

check_boxKey Events

• Hudson Bay Financing Approval Sought

  Stockholders will vote on authorizing the reservation and issuance of up to 8,000,000 common shares to Hudson Bay Master Fund Ltd. This is a compliance requirement for a Securities Purchase Agreement that closed on October 22, 2025.

• Significant Potential Dilution

  The potential issuance of 8,000,000 shares represents approximately 25.14% dilution based on the 31,823,985 shares outstanding as of April 1, 2026.

• Favorable Pricing for Past Capital Raise

  The initial shares were sold at $1.90 and pre-funded warrants at $1.8999, both above the current stock price of $1.67. This transaction provided approximately $7.6 million in capital, a substantial amount for the company.

• Routine Annual Meeting Proposals

  The proxy statement also includes proposals for the election of five directors and the ratification of Forvis Mazars, LLP as the independent registered public accounting firm for the 2026 fiscal year.

auto_awesomeAnalysis

Spectral AI is seeking shareholder approval for the reservation and issuance of up to 8 million common shares to Hudson Bay Master Fund Ltd. This vote is required by Nasdaq rules for a Securities Purchase Agreement that closed on October 22, 2025. The transaction initially provided approximately $7.6 million in capital from the sale of 3.065 million shares at $1.90 per share and 935,000 pre-funded warrants at $1.8999 each. Additionally, 4 million warrants with an exercise price of $2.51 were issued. While the potential issuance of 8 million shares represents significant dilution (approximately 25% of current outstanding shares), the initial capital raise was substantial for the company (over 14% of its market cap) and was priced at a premium to the current stock price of $1.67. This financing likely contributed to the company's recently reported financial improvements, including a tripling of cash by year-end 2025 and a $31.7 million non-dilutive funding advance from BARDA. The current vote is a compliance measure to allow the full potential issuance under the existing agreement.